T1	Outcomes 13 68	triglyceride/high-density lipoprotein cholesterol ratio
T2	Outcomes 144 168	coronary atherosclerosis
T3	Outcomes 909 938	Coronary atheroma progression
T4	Outcomes 993 1099	relationship between changes in biochemical parameters, percent atheroma volume, and total atheroma volume
T5	Outcomes 1190 1312	high-density lipoprotein cholesterol (HDL-C) and reductions in glycated hemoglobin, triglycerides, and C-reactive protein.
T6	Outcomes 1360 1412	changes in percent atheroma volume and triglycerides
T7	Outcomes 1435 1459	triglyceride/HDL-C ratio
T8	Outcomes 1486 1505	glycated hemoglobin
T9	Outcomes 1550 1596	changes in low-density lipoprotein cholesterol
T10	Outcomes 1620 1636	apolipoprotein B
T11	Outcomes 1664 1682	apolipoprotein A-I
T12	Outcomes 1831 1836	HDL-C
T13	Outcomes 1887 1900	triglycerides
T14	Outcomes 1932 1956	triglyceride/HDL-C ratio
T15	Outcomes 2002 2021	glycated hemoglobin
T16	Outcomes 2120 2138	triglyceride/HDL-C
T17	Outcomes 2171 2194	percent atheroma volume
T18	Outcomes 2210 2231	total atheroma volume
T19	Outcomes 2297 2321	triglyceride/HDL-C ratio
T20	Outcomes 2346 2366	atheroma progression
